Novel vasodilatory effect of intracisternal injection of magnesium sulfate solution on spastic cerebral arteries in the canine two-hemorrhage model of subarachnoid hemorrhage: Laboratory investigation

Journal of Neurosurgery

Volumn 110, Issue 1, 2009, Pages 73-78

  Mori, Kentaro ^a   Miyazaki, Masahiro ^a   Hara, Yasukazu ^a   Aiko, Yasuhisa ^a   Yamamoto, Takuji ^a   Nakao, Yasuaki ^a  

^a JUNTENDO UNIVERSITY   (Japan)

Author keywords

Cerebrospinal fluid; Magnesium sulfate; Subarachnoid hemorrhage; Vasospasm

Indexed keywords

MAGNESIUM SULFATE; VASODILATOR AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY DIAMETER; ARTICLE; BASILAR ARTERY; BRAIN ANGIOGRAPHY; BRAIN ARTERY; BRAIN VASOSPASM; CEREBROSPINAL FLUID; CISTERNA MAGNA; CONTROLLED STUDY; DRUG BRAIN LEVEL; DRUG EFFICACY; EXPERIMENTAL DOG; FEMALE; NONHUMAN; PRIORITY JOURNAL; SUBARACHNOID HEMORRHAGE; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE; VASODILATATION; VERTEBRAL ARTERY; ANIMAL; DOG; DRUG EFFECT; INJECTION; PATHOLOGY; PATHOPHYSIOLOGY; SOLUTION AND SOLUBILITY;

ANIMALS; CEREBRAL ANGIOGRAPHY; CEREBRAL ARTERIES; CISTERNA MAGNA; DOGS; INJECTIONS; MAGNESIUM SULFATE; SOLUTIONS; SUBARACHNOID HEMORRHAGE; VASODILATOR AGENTS; VASOSPASM, INTRACRANIAL;

EID: 60749100984     PISSN: 00223085     EISSN: 19330693     Source Type: Journal    
DOI: 10.3171/2008.4.17494     Document Type: Article

References (37)

1. Allen GS, Ahn HS, Preziosi TJ, Battye R, Boone SC, Boone SC, et al: Cerebral arterial spasm - a controlled trial of nimodipine in patients with subarachnoid hemorrhage. N Engl J Med 308:619-624, 1983
2. Altura BT, Altura BM: Withdrawal of magnesium causes vasospasm while elevated magnesium produces relaxation of tone in cerebral arteries. Neurosci Lett 20:323-327, 1980
3. Betz E, Heuser D: Actions and interactions of cations and anions on pial arteries. Adv Neurol 20:71-76, 1978
4. Chia RY, Hughes RS, Morgan MK: Magnesium: a useful adjunct in the prevention of cerebral vasospasm following aneurysmal subarachnoid haemorrhage. J Clin Neurosci 9:279-281, 2002
5. Dorhout Mees SM, Rinkel GJE, Feigin VL, Algra A, van den Bergh WM, Vermeulen M, et al: Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev 1:CD000277, 2007
6. Dorsch NW: Therapeutic approaches to vasospasm in subarachnoid hemorrhage. Curr Opin Crit Care 8:128-133, 2002
7. Hop JW, Rinkel GJ, Algra A, van Gijin J: Case-fatality rates and functional outcome after subarachnoid hemorrhage: a systematic review. Stroke 28:660-664, 1997 (Pubitemid 27118394)
8. Hughes JT, Schianchi PM: Cerebral artery spasm. A histological study at necropsy of the blood vessels in cases of subarachnoid hemorrhage. J Neurosurg 48:515-525, 1978
9. Kassell NF, Helm G, Simmons N, Phillips CD, Cail WS: Treatment of cerebral vasospasm with intraarterial papaverine. J Neurosurg 77:848-852, 1992
10. Kasuya H, Onda H, Sasahara A, Takeshita M, Hori T: Application of nicardipine prolonged-release implants: analysis of 97 consecutive patients with acute subarachnoid hemorrhage. Neurosurgery 56:895-902, 2005 (Pubitemid 40628076)
11. Kemp PA, Gardiner SM, March JE, Rubin PC, Bennett T: Assessment of the effects of endothelin-1 and magnesium sulfate on regional blood flows in conscious rats, by the coloured microsphere reference technique. Br J Pharmacol 126:621-626, 1999
12. Macdonald RL, Curry DJ, Aihara Y, Zhang ZD, Jahromi BS, Yassari R: Magnesium and experimental vasospasm. J Neurosurg 100:106-110, 2004 (Pubitemid 38017822)
13. Macdonald RL, Pluta RM, Zhang JH: Cerebral vasospasm after subarachnoid hemorrhage: the emerging revolution. Nat Clin Pract Neurol 3:256-263, 2007
14. Macdonald RL, Weir B: Cerebral vasospasm: prevention and treatment, in Batjer HH, Caplan LR, Friberg L, Greenlee RG Jr, Kopitnik TA Jr, Young WL (eds): Cerebrovascular Disease. Philadelphia: Lippincott-Raven, 1997, pp 1111-1121
15. ++-effect on the contractions of bovine cerebral artery.] No Shinkei Geka 16:1251-1259, 1988 (Jpn)
16. Mocco J, Zacharia BE, Komotar RJ, Connolly ES Jr: A review of current and future medical therapies for cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Neurosurg Focus 21(3):E9, 2006
17. Mori K, Miyazaki M, Iwata J, Yamamoto T, Nakao Y: Intracisternal infusion of magnesium sulfate solution improved re duced cerebral blood flow induced by experimental subarachnoid hemorrhage in the rat. Neurosurg Rev 31:197-203, 2008
18. Muroi C, Terzic A, Fortunati M, Yonekawa Y, Keller E: Magnesium sulfate in the management of patients with aneurysmal subarachnoid hemorrhage: a randomized, placebo-controlled, dose-adapted trial. Surg Neurol 69:33-39, 2008 (Pubitemid 350181007)
19. Origitano TC, Wascher TM, Reichman OH, Anderson DE: Sustained increased cerebral blood flow with prophylactic hy pertensive hypervolemic hemodilution ("triple H" therapy) after subarachnoid hemorrhage. Neurosurgery 27:729-739, 1990
20. Pluta RM: Delayed cerebral vasospasm and nitric oxide: review, new hypothesis, and proposed treatment. Pharmacol Ther 105:23-56, 2005
21. Pyne GJ, Cadoux-Hudson AD, Clark JF: Magnesium protection against in vitro cerebral vasospasm after subarachnoid haemorrhage. Br J Neurosurg 15:409-415, 2001
22. Ram Z, Sadeh M, Sahar A, Hadani M: Magnesium sulfate reverses experimental delayed cerebral vasospasm after subarachnoid hemorrhage in rats. Stroke 22:922-927, 1991
23. Sanders KM: Signal transduction in smooth muscle. Invited review: mechanism of calcium handling in smooth muscles. J Appl Physiol 91:1438-1449, 2001
24. Sasahara A, Kasuya H, Kawashima A, Aihara Y, Izawa M, Hori T: [The efficacy and safety of the nicardipine prolonged-release implant in a canine double hemorrhage model.] No Shinkei Geka 28:1071-1075, 2000 (Jpn)
25. Schmid-Elsaesser R, Kunz M, Zausinger S, Prueckner S, Briegel J, Steiger HJ: Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study. Neurosurgery 58:1054-1065, 2006 (Pubitemid 43879539)
26. Seelig JM, Wei EP, Kontos HA, Choi SC, Becker DP: Effect of changes in magnesium ion concentration on cat cerebral ar terioles. Am J Physiol 245:H22-H26, 1983
27. Sehba FA, Bederson JB: Mechanisms of acute brain injury after subarachnoid hemorrhage. Neurol Res 28:381-398, 2006
28. Seifert V, Stolke D, Reale E: Ultrastructural changes of the basilar artery following experimental subarachnoid haemorrhage. Acta Neurochir (Wien) 100:164-171, 1989
29. Stippler M, Crago E, Levy EI, Kerr ME, Yonas H, Horowitz MB, et al: Magnesium infusion for vasospasm prophylaxis af ter subarachnoid hemorrhage. J Neurosurg 105:723-729, 2006
30. Suzuki M, Doi M, Otawara Y, Ogasawara K, Ogawa A: Intrathecal administration of nicardipine hydrochloride to prevent vasospasm in patients with subarachnoid hemorrhage. Neurosurg Rev 24:180-184, 2001 (Pubitemid 34003132)
31. Tejada JG, Tayor RA, Ugurel MS, Hayakawa M, Lee SK, Chaloupka JC: Safety and feasibility of intra-arterial nicardipine for the treatment of subarachnoid hemorrhage-associated vasospasm: initial clinical experience with high-dose infusions. AJNR Am J Neuroradiol 28:844-848, 2007 (Pubitemid 46776059)
32. Turlapaty PD, Altura BM: Extracellular magnesium ions control calcium exchange and content of vascular smooth muscle. Eur J Pharmacol 52:421-423, 1978
33. Turlapaty PD, Altura BM: Magnesium deficiency produces spasms of coronary arteries: relationship to etiology of sudden death ischemic heart disease. Science 208:198-200, 1980
34. van den Bergh WM, Albrecht KW, Berkelbach van der Sprenkel JW, Rinkel GJ: Magnesium therapy after aneurysmal subarachnoid haemorrhage a dose-finding study for long term treatment. Acta Neurochir (Wien) 145:195-199, 2003
35. van den Bergh WM, Dijkhuizen RM, Rinkel GJE: Potentials of magnesium treatment in subarachnoid haemorrhage. Magnes Res 17:301-313, 2004
36. Varsos VG, Liszcrak TM, Han DH, Kistler JP, Vielma J, Black PM, et al: Delayed cerebral vasospasm is not reversible by aminophylline, nifedipine, or papaverine in a 'two-hemorrhage' canine model. J Neurosurg 58:11-17, 1983
37. Veyna RS, Seyfried D, Burke DG, Zimmerman C, Mlynarek M, Nichols V, et al: Magnesium sulfate therapy after aneurysmal subarachnoid hemorrhage. J Neurosurg 96:510-514, 2002 (Pubitemid 34230205)